Epstein-Barr virus: evasive maneuvers in the development of PTLD.
about
Emerging therapeutic strategies for Epstein-Barr virus+ post-transplant lymphoproliferative disorderThe interplay between Epstein-Barr virus and B lymphocytes: implications for infection, immunity, and diseaseClinical immune-monitoring strategies for predicting infection risk in solid organ transplantationSensitive, microliter PCR with consensus degenerate primers for Epstein Barr virus amplificationLong-term risk of malignancy among patients treated with immunosuppressive agents for ocular inflammation: a critical assessment of the evidence.Humoral immune responses to Epstein-Barr virus encoded tumor associated proteins and their putative extracellular domains in nasopharyngeal carcinoma patients and regional controls.EBV-specific CD8+ T cells from asymptomatic pediatric thoracic transplant patients carrying chronic high EBV loads display contrasting features: activated phenotype and exhausted functionBurkitt lymphoma: pathogenesis and immune evasion.Detection of EBV genomes in plasmablasts/plasma cells and non-B cells in the blood of most patients with EBV lymphoproliferative disorders by using Immuno-FISH.Post-transplant lymphoproliferative disorder resembling Wilms tumor. Diagnostic dilemma: renal biopsy or nephrectomy?Syk activation of phosphatidylinositol 3-kinase/Akt prevents HtrA2-dependent loss of X-linked inhibitor of apoptosis protein (XIAP) to promote survival of Epstein-Barr virus+ (EBV+) B cell lymphomas.Treating rheumatic patients with a malignancy.HLA class II defects in Burkitt lymphoma: bryostatin-1-induced 17 kDa protein restores CD4+ T-cell recognitionPosttransplant lymphoproliferative disease after lung transplantation.Epstein-Barr virus, rapamycin, and host immune responses.NKG2A-Expressing Natural Killer Cells Dominate the Response to Autologous Lymphoblastoid Cells Infected with Epstein-Barr Virus.Using Epstein-Barr viral load assays to diagnose, monitor, and prevent posttransplant lymphoproliferative disorder.Lymphoproliferative disorders after solid organ transplantation-classification, incidence, risk factors, early detection and treatment options.Post-transplant lymphoproliferative disorder following kidney transplantation: a population-based cohort study.Virus-specific T-cell banks for 'off the shelf' adoptive therapy of refractory infections.Epstein-Barr Virus-Positive Posttransplant Lymphoproliferative Disease After Solid Organ Transplantation: Pathogenesis, Clinical Manifestations, Diagnosis, and Management.Disruption of HLA class II antigen presentation in Burkitt lymphoma: implication of a 47,000 MW acid labile protein in CD4+ T-cell recognition.Syk-induced phosphatidylinositol-3-kinase activation in Epstein-Barr virus posttransplant lymphoproliferative disorder.Thymoquinone efficiently inhibits the survival of EBV-infected B cells and alters EBV gene expression.Dominant-negative derivative of EBNA1 represses EBNA1-mediated transforming gene expression during the acute phase of Epstein-Barr virus infection independent of rapid loss of viral genome.Primary Epstein-Barr virus infection, seroconversion, and post-transplant lymphoproliferative disorder in seronegative renal allograft recipients: a prospective cohort study.Post-Transplant Lymphoproliferative Disorder Presenting as CD20-Negative Plasmablastic Lymphoma in the Lung.Increased incidence of adenoidectomy and tonsillectomy in children with renal transplantation.Epstein-Barr virus and posttransplant lymphoproliferative disorder in solid organ transplantation.Post-transplantation lymphoproliferative disease: Epstein-Barr virus DNA levels, HLA-A3, and survival.Epidemiology and morbidity of Epstein-Barr virus infection in pediatric renal transplant recipients: a multicenter, prospective study.Molecular diagnosis of Epstein-Barr virus infections.Impact of Epstein-Barr virus donor and recipient serostatus on the incidence of post-transplant lymphoproliferative disorder in kidney transplant recipients.Comprehensive review of post-organ transplant hematologic cancers.Posttransplant Lymphoproliferative Disorder in Adults Receiving Kidney Transplantation in British Columbia: A Retrospective Cohort Analysis.
P2860
Q26859114-C40C088A-D356-42FA-AD55-80438C510C64Q26998401-E3AB4BBE-CA1B-469D-BAAE-E33F8221C518Q26998832-1BA6F3BD-C367-4265-AFEA-E26583CA1077Q30356173-40353C0B-370B-4B45-9B0B-AB01FCB373FFQ33346685-57AAB735-21D2-4FB0-B08C-77D1DA205521Q33822681-AE884539-567F-4539-82BC-A3F74ED026AFQ34186560-5C330119-A6E3-4C68-BF40-B00EED9B3B32Q34189497-F4FE19AF-AC02-4EA7-8490-0BF52B9C7748Q34374063-EA526A88-B2FA-4621-9F8B-D8210EB3872BQ34622006-C7F79CAD-30DF-492A-94DA-BE08CD3E969AQ35423739-A47C55DD-DB45-42E4-A1C3-27FDF5256913Q35557863-9FC45FBA-AF6A-4F4A-A303-047AB1AFFE61Q35582198-D70B6A40-AEE2-4E75-AECC-1D74C63A53BBQ36701511-DF6CFFF4-A488-4914-A32A-A64C069DDD6FQ37342546-07C2F602-AD4F-4E60-B58B-EDD452E8C12AQ37503717-A128CE1B-E4EF-49A0-952B-529E4B0238D3Q37726624-4251F72B-47FC-48F4-8570-530240920713Q37824825-F64B1892-A8B6-4E2A-8C2D-86F9935E2612Q38691467-3628909F-7F5A-4889-97E0-B5B3727A2C4CQ38797555-C8D3D6DA-5E7D-4D3D-9D98-A05B9B85CC8CQ38833567-A37BF39E-8CF1-4C8D-8617-D0B795182D59Q39015659-B63E1FCA-C522-48D3-8789-C830B468D3CCQ39164486-1BDE6D8E-15F2-458A-B745-A7565FDEE458Q39254946-C8E8A17D-D5E8-4AB4-994B-102ECAEBEA4DQ39743759-24279853-9AE9-406B-B49B-A9BBF63A28A8Q39887714-FE2A840E-7009-4FED-ADD4-52F70800572DQ40504797-29E49985-EF5E-4BAB-8C17-D692F86E842DQ42234395-43BE5AAD-2D39-440A-B586-1964C6EBC738Q42272334-79E61D95-B9DF-4A2B-9D67-69CF0C34FC9AQ43407559-7C75C874-1D2E-4695-B3E8-261099AD3546Q44061780-D23F0858-D79C-450C-AB30-DFFCABC3A0C4Q45352227-97EF7271-3495-40E7-942D-4F9FCA16804AQ45360184-31DF5C36-DFFA-4F62-A19D-A2EEF0ECAC09Q47572480-0FEF975D-388C-4C31-B2C0-0D03E416BE6EQ52595061-64974B01-00D6-4521-B46D-0B015700520C
P2860
Epstein-Barr virus: evasive maneuvers in the development of PTLD.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Epstein-Barr virus: evasive maneuvers in the development of PTLD.
@ast
Epstein-Barr virus: evasive maneuvers in the development of PTLD.
@en
type
label
Epstein-Barr virus: evasive maneuvers in the development of PTLD.
@ast
Epstein-Barr virus: evasive maneuvers in the development of PTLD.
@en
prefLabel
Epstein-Barr virus: evasive maneuvers in the development of PTLD.
@ast
Epstein-Barr virus: evasive maneuvers in the development of PTLD.
@en
P2860
P1476
Epstein-Barr virus: evasive maneuvers in the development of PTLD
@en
P2093
Olivia M Martinez
P2860
P304
P356
10.1111/J.1600-6143.2006.01650.X
P407
P577
2007-01-04T00:00:00Z